Laboratory of Optical Bioimaging and Spectroscopy


Many diseases usually have coexisting metabolic dysfunction. The SRS imaging platform can be used to identify early stage in situ metabolic changes during the progression of aging, obesity, development, neurodegenerative diseases, cancer, and more.



De novo syntheses of proteins in cancer (top) and GFP neurons in the brain cortex layer.